世界中医药
文章摘要
引用本文:魏华民,赵引,段佳易,王子健,姚伟伟,李杨帆,俞静,林海.胃癌前病变的核心病机及方药[J].世界中医药,2020,(22):.  
胃癌前病变的核心病机及方药
Core Pathogenesis and Prescription of Gastric Precancerous Lesion
投稿时间:2020-01-02  
DOI:10.3969/j.issn.1673-7202.2020.22.029
中文关键词:  胃癌前病变  核心病机  半夏泻心汤  中医学
English Keywords:Gastric precancerous lesion  Core pathogenesis  Banxia Xiexin Decoction  TCM
基金项目:国家自然科学基金项目(81904102);北京市自然科学基金项目(7184203)
作者单位
魏华民,赵引,段佳易,王子健,姚伟伟,李杨帆,俞静,林海 首都医科大学附属北京友谊医院,北京,100050 
摘要点击次数: 383
全文下载次数: 0
中文摘要:
      胃癌前病变的逆转对预防胃癌发生有重要意义。但由于缺乏典型症状、体征,导致临床中认识多样、治疗方法混杂。对该病核心病机的深入认识是发挥中医药优势,有效预防胃癌的关键。本文从胃癌前病变的宏观现象、微观现象、分子机制和临床药理4个方面搜索证据,探讨了胃癌前病变的核心病机及方药,初步探索了该病的核心病机确立原则和方法。
English Summary:
      Reversion of gastric precancerous lesion is important for the prevention of gastric cancer.There are different understanding and treatments about it,due to lacking of typical symptoms and physical signs.Deep understanding of its core pathogenesis is the key to exert superiority of traditional Chinese medicine and prevent gastric cancer.Evidences are collected from 4 aspects including macro phenomenon,microphenomenon,molecular mechanism and clinical pharmacology core pathogenesis and prescription of gastric precancerous lesion,initially establishing the principles and methods of the pathogenesis of the disease.
查看全文  查看/发表评论  下载PDF阅读器